These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35840767)

  • 1. Pregnancy outcomes after first-trimester exposure to buspirone: prospective longitudinal outcomes from the MGH National Pregnancy Registry for Psychiatric Medications.
    Freeman MP; Szpunar MJ; Kobylski LA; Harmon H; Viguera AC; Cohen LS
    Arch Womens Ment Health; 2022 Oct; 25(5):923-928. PubMed ID: 35840767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of major malformations in infants after first-trimester exposure to benzodiazepines: Results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications.
    Szpunar MJ; Freeman MP; Kobylski LA; Caplin PS; Gaccione P; Viguera AC; Chitayat D; Hernández-Díaz S; Cohen LS
    Depress Anxiety; 2022 Dec; 39(12):751-759. PubMed ID: 35909254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Major Malformations Following First-Trimester Exposure to Olanzapine: Preliminary Data From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications.
    Viguera AC; Freeman MP; Kobylski LA; Rossa ET; Gaccione P; Chitayat D; Hernández-Díaz S; Cohen LS
    J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):106-112. PubMed ID: 36825887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.
    Viguera AC; Freeman MP; Góez-Mogollón L; Sosinsky AZ; McElheny SA; Church TR; Young AV; Caplin PS; Chitayat D; Hernández-Díaz S; Cohen LS
    J Clin Psychiatry; 2021 Aug; 82(4):. PubMed ID: 34352165
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of Major Malformations in Infants After First-Trimester Exposure to Stimulants: Results From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications.
    Szpunar MJ; Freeman MP; Kobylski LA; Rossa ET; Gaccione P; Chitayat D; Viguera AC; Cohen LS
    J Clin Psychopharmacol; 2023 Jul-Aug 01; 43(4):326-332. PubMed ID: 37235505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary results on pregnancy outcomes in women using lamotrigine.
    Tennis P; Eldridge RR;
    Epilepsia; 2002 Oct; 43(10):1161-7. PubMed ID: 12366730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.
    Freeman MP; Viguera AC; Góez-Mogollón L; Young AV; Caplin PS; McElheny SA; Church TR; Chitayat D; Hernández-Díaz S; Cohen LS
    Arch Womens Ment Health; 2021 Aug; 24(4):659-667. PubMed ID: 33710399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine.
    Cohen LS; Góez-Mogollón L; Sosinsky AZ; Savella GM; Viguera AC; Chitayat D; Hernández-Díaz S; Freeman MP
    Am J Psychiatry; 2018 Dec; 175(12):1225-1231. PubMed ID: 30111186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.
    Cohen LS; Viguera AC; McInerney KA; Freeman MP; Sosinsky AZ; Moustafa D; Marfurt SP; Kwiatkowski MA; Murphy SK; Farrell AM; Chitayat D; Hernández-Díaz S
    Am J Psychiatry; 2016 Mar; 173(3):263-70. PubMed ID: 26441156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.
    Djulus J; Koren G; Einarson TR; Wilton L; Shakir S; Diav-Citrin O; Kennedy D; Voyer Lavigne S; De Santis M; Einarson A
    J Clin Psychiatry; 2006 Aug; 67(8):1280-4. PubMed ID: 16965209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India.
    Thomas SV; Jose M; Divakaran S; Sankara Sarma P
    Epilepsia; 2017 Feb; 58(2):274-281. PubMed ID: 28084641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.
    Ephross SA; Sinclair SM
    Headache; 2014; 54(7):1158-72. PubMed ID: 24805878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of the National Pregnancy Registry for Atypical Antipsychotics.
    Cohen LS; Viguera AC; McInerney KA; Kwiatkowski MA; Murphy SK; Lemon EL; Hernández-Díaz S
    J Clin Psychiatry; 2015 Jul; 76(7):986-9. PubMed ID: 25939066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations.
    Huybrechts KF; Hernández-Díaz S; Patorno E; Desai RJ; Mogun H; Dejene SZ; Cohen JM; Panchaud A; Cohen L; Bateman BT
    JAMA Psychiatry; 2016 Sep; 73(9):938-46. PubMed ID: 27540849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations.
    Charlton RA; Weil JG; Cunnington MC; Ray S; de Vries CS
    Drug Saf; 2011 Feb; 34(2):157-71. PubMed ID: 21247222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium.
    Huybrechts KF; Bröms G; Christensen LB; Einarsdóttir K; Engeland A; Furu K; Gissler M; Hernandez-Diaz S; Karlsson P; Karlstad Ø; Kieler H; Lahesmaa-Korpinen AM; Mogun H; Nørgaard M; Reutfors J; Sørensen HT; Zoega H; Bateman BT
    JAMA Psychiatry; 2018 Feb; 75(2):167-175. PubMed ID: 29238795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of first trimester prescription opioid use with congenital malformations in the offspring: population based cohort study.
    Bateman BT; Hernandez-Diaz S; Straub L; Zhu Y; Gray KJ; Desai RJ; Mogun H; Gautam N; Huybrechts KF
    BMJ; 2021 Feb; 372():n102. PubMed ID: 33568363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
    Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.
    Huybrechts KF; Bateman BT; Pawar A; Bessette LG; Mogun H; Levin R; Li H; Motsko S; Scantamburlo Fernandes MF; Upadhyaya HP; Hernandez-Diaz S
    BMJ; 2020 Feb; 368():m237. PubMed ID: 32075794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin use early in pregnancy and the risk of major congenital malformations.
    Patorno E; Bateman BT; Huybrechts KF; MacDonald SC; Cohen JM; Desai RJ; Panchaud A; Mogun H; Pennell PB; Hernandez-Diaz S
    Neurology; 2017 May; 88(21):2020-2025. PubMed ID: 28446648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.